Natco Pharma Limited has informed the Exchange about Schedule of meet
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has scheduled an earnings call with investors and analysts on Wednesday, August 13, 2025, at 11:00 AM IST. The call will discuss the company's unaudited financial results for Q1FY26, covering the quarter ended June 30, 2025. Vice-Chairman and CEO Mr. Rajeev Nannapaneni and Executive Vice President Mr. Rajesh Chebiyam will represent the company. The call is being hosted by Batlivala & Karani Securities, with dial-in access provided for participants in India and several international locations.
This is a routine quarterly results announcement and typically does not move the stock on its own. Investors should listen in for any commentary on revenue growth, margins, U.S. generics business, and forward guidance for the rest of FY26.